• Pfizer's Departing C.E.O. Will Be Known for the Deals He Didn't Complete

    2 monthes ago - By NY Times

    Ian Read leaves the pharmaceutical company, with eight years of deal-making tarnished by two failed takeovers aimed at moving earnings overseas.
    Read more ...